:: Current Investments

• Xing Ling International Pte. Ltd.
  Xing Ling International Pte. Ltd., which is majority-owned by Orchid Capital, is a Singapore-based global exclusive representative for large Chinese pharmaceutical groups, and distributes a reputable range of Chinese and Western medicine. The company has secured global representation rights from top pharmaceutical and Traditional Chinese Medicine (TCM) companies in China, the most significant of which are the Topsun and Kinna Groups.
  
  Xing Ling's key principal, the Topsun Group, is the 5th largest privately-owned pharmaceutical enterprise in China, with a turnover of RMB 2 billion (US$248million) in 2004. The Group operates 19 factories boasting current Good Manufacturing Practices (cGMP) certifications and has a 10,000-strong workforce. Topsun produces a massive range of heritage TCM formulations and cost-effective Western generic drugs including antibiotics, anti-hypertensives, opthalmics and biologics.
   
• Orchid EMARB Ltd
  Orchid EMARB Ltd is an international offshore fund, established in 2002 with funds of 2.5 million Euro. The fund invests in various securities, mainly bonds of investment grade or better.
   
• Gongyou Machines Ltd.
  Orchid’s largest investment is a share of (per August 2007) about 10% in this leading producer of woodworking machines, based in Weihai (China). Orchid was the lead investor in the pre-IPO-investment round in Summer 2006. Gongyou succeeded as the first-ever Chinese company with a primary listing in Germany, an event extensively covered by German media. Gongyou is a sizable group with more than 1300 staff and with outstanding competitive advantages: Low production costs, significant economies of scale based on an annual output of about half a million machines, and a product range of more than 200 machine types, developed by an R&D team of 150 engineers. This enables Gongyou to penetrate more and more export markets, mainly emerging markets like ASEAN, Russia and Latin America. These are regions with a booming furniture and construction industry. Gongyou has been profitable for many years and recorded a net profit of more than AU$ 5 million in last financial year. Gongyou currently significantly expands its production capacity. More information on Gongyou: www.gongyoumachines.com.
  
  
• RGM Entertainment Pte. Ltd.
  RGM is a Singapore-based Asian media group. The Australian subsidiary of RGM has started as a successful talent agency in 1982. Currently, RGM is not only Australasia’s leading agency for actors, directors and script writers, but also the executive producer of several movies with a high calibre international cast. RGM is backed by the Singapore government’s Media Development Agency (MDA) with a film financing facility. We are looking forward to the premiere of these movies, and are optimistic for an IPO of RGM in 2008. More information on RGM: www.rgm.com.sg.